BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
Menu

Report Library

All Reports
Datamonitor Healthcare CV&Met Disease Analysis: Diabetic Nephropathy

November 19, 2020

Diabetic nephropathy (DN) involves structural and functional damage to the kidney's filtering apparatus, the glomeruli, resulting from diabetes. The diagnosis is usually inferred without a biopsy, so in the US the term “diabetic kidney disease” is preferred, referring to a presumptive diagnosis of kidney disease caused by diabetes.

DN may occur in 17–60% of diabetics, depending on the country. It is a leading cause of end-stage renal disease (ESRD) in the developed world, although patients can have a quite variable course, and only a minority progress to ESRD with contemporary treatment. DN also imparts a higher risk for cardiovascular disease (CVD) beyond that for diabetes alone.

This Datamonitor Healthcare report contains a Disease Analysis module.

Indications Covered: Diabetic Nephropathy
Back to the top Back to the top